Yes. You do not need to wait until methamphetamine or other stimulants clear your system before starting treatment at Ideal Option.

Ideal Option utilizes a low-barrier admission protocol. For safety, medical assessments, vitals, and laboratory testing are conducted during your initial visit to evaluate your current physical health and tailor a recovery plan to your specific needs.

Evidence & Authoritative Reference: The Substance Abuse and Mental Health Services Administration (SAMHSA) stresses that immediate, low-barrier entry into treatment is critical for individuals using methamphetamine, as delays significantly increase the risk of severe cardiovascular events, overdose, and psychiatric crises (SAMHSA Treatment for Stimulant Use Disorders).

Illicit methamphetamine poses immediate dangers due to extreme cardiovascular strain and widespread contamination with synthetic opioids like fentanyl.

Chronic methamphetamine use severely impacts dopamine regulation, leading to intense fatigue, severe depression, paranoia, and memory deficits during cessation. Medical supervision helps manage these withdrawal phases while reducing the risk of fatal overdose from contaminated illicit street supplies.

Evidence & Authoritative Reference: The U.S. Food and Drug Administration (FDA) and NIDA highlight the urgent public health threat of the overlapping stimulant and opioid epidemics, advocating for integrated medical monitoring and harm-reduction strategies to prevent fatal poisoning (FDA Stimulant & Opioid Co-Use Public Health Strategy).

The combination of naltrexone and bupropion is strictly for isolated methamphetamine use disorder.

If you are using meth and opioids together, we will develop a personalized treatment plan for you that may include buprenorphine (Suboxone). We have successfully treated many patients using multiple substances and can help you too.

Naltrexone-bupropion is not approved for use in people under the age 18. Younger adolescents in need of treatment should be referrred to a clinician or program specializing in adolescent addiction.

Studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of naltrexone and bupropion combination in older adults. However, elderly patients may be more sensitive to the effects of this medicine and are more likely to have age-related kidney problems. This may require extra caution and an adjustment in dosing for patients receiving this medicine.

Unfortunately, naltrexone-bupropion is not recommended for use during pregnancy as it may harm the fetus.